How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

9,526 results for

E/M Medical Decision Making

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics

of Endocrinology, Boston Children’ s Hospital, Boston, Massachusetts, USA; 8 American College of Medical Genetics and Genomics, Bethesda, Maryland, USA. Correspondence: Michael S. W atson (mwatson@acmg.net) Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics Priya S. Kishnani, MD 1 , Stephanie L. Austin, MS, MA 1 , Jose E. Abdenur, MD 2 , Pamela Arn, MD 3 , Deeksha S. Bali, PhD 1 , Anne Boney, MED, RD 1 , Wendy K. Chung, MD (...) and hyponatremia in the setting of i.v. glucose administration. 145,146 In addition, the use of a fibrinolytic inhibitor, such as e-aminocaproic acid (Amicar), can be used as an adjunctive medication if there is mucosal-associated bleeding. For oral hemorrhage, Amicar can be given as a solution to “swish for 30 seconds and spit” at a dose of 1.25?g four times daily. For more severe mucosal-associated bleeding, an i.v. bolus of 4?g in 250?ml of D5W/NS infused over 1 hour followed by a drip of 1?g/h (50?ml/h

2014 American College of Medical Genetics and Genomics

142. Medical Management of Kidney Stones

Medical Management of Kidney Stones Kidney Stones: Medical Mangement Guideline - American Urological Association advertisement Toggle navigation About Us About the AUA Membership AUA Governance Industry Relations Education AUAUniversity Education Products & Resources Normal Histology and Important Histo-anatomic Structures Urinary Bladder Prostate Kidney Renovascular Diseases Andrenal Gland Testis Paratesticular Tumors Penis Retroperitoneum Cytology Online Learning For Medical Students Exams (...) Safety and Quality of Care Accreditations and Reporting Patient Education Medical Management of Kidney Stones (2014) Published 2014 The purpose of the clinical guideline on Medical Management of Kidney Stones is to provide a clinical framework for the diagnosis, prevention and follow-up of adult patients with kidney stones based on the best available published literature. Topics covered include evaluation, diet therapy, pharmacologic therapy, and follow-up. [pdf] Panel Members Margaret Sue Pearle, MD

2014 American Urological Association

143. Medical Management of First-Trimester Abortion

D. Creinin, MD and Daniel A. Grossman, MD. The information is designed to aid practitioners in making decisions about appropriate obstetric and gynecologic care. These guidelines should not be construed as dictating an exclusive course of treatment or procedure. Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to the institution or type of practice. Medical Management of First-Trimester Abortion Over the past three decades (...) comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. MOD Study Trial Group. 7 von Hertzen H, Huong NT, Piaggio G, Bayalag M, Cabezas E, Fang AH, et al. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial. WHO Research Group on Postovulatory Methods of Fertility Regulation. 8 Creinin MD, Vittinghoff E, Schaff E, Klaisle C, Darney PD, Dean C. Medical abortion with oral methotrexate and vaginal misoprostol

2014 American College of Obstetricians and Gynecologists

144. Efficacy and safety of medical marijuana in selected neurologic disorders

Sciences Center, Albuquerque; the Department of Neurology (G.G.), University of Kansas School of Medicine, Kansas City; and the Department of Neurology (D.G.), Geisinger Health System, Danville, PA. Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders Barbara S. Koppel , John C.M. Brust , Terry Fife , Jeff Bronstein , Sarah Youssof , Gary Gronseth , David Gloss Neurology Apr 2014, 82 (17) 1556-1563; DOI: 10.1212/WNL.0000000000000363 Citation Manager Formats Make (...) with seizure disorders, e4 concluded there is sufficient evidence to prescribe CBDs or recommend self-treatment with smoked marijuana. ADVERSE EFFECTS In looking at marijuana-related AEs, we excluded studies that reanalyzed earlier studies, used a single dose of medication, or had Class IV evidence or unclear information about AEs. , , , ,e2,e3 See table e-6 for details. Overall, 1,619 patients were treated with cannabinoids for less than 6 months. Meta-analysis of simple proportions yielded 6.9% (95% CI

2014 American Academy of Neurology

145. Guidelines on Sedation and/or Analgesia for Diagnostic and Interventional Medical, Dental or Surgical Procedures

should be discharged into the care of a responsible adult to whom written instructions should be given, including advice about eating and drinking, pain relief, and resumption of normal activities, as well as about making legally-binding decisions, driving, or operating machinery. 12.5 A system should be in place to enable safe transfer of the patient to appropriate medical care should the need arise. 13. TRAINING IN PROCEDURAL SEDATION AND/OR ANALGESIA FOR NON- ANAESTHETIST MEDICAL PRACTITIONERS (...) Guidelines on Sedation and/or Analgesia for Diagnostic and Interventional Medical, Dental or Surgical Procedures PS09 2014 Page 1 PS09 2014 Australian and New Zealand College of Anaesthetists (ANZCA) Faculty of Pain Medicine The following organisations have endorsed this document: Australasian College for Emergency Medicine College of Intensive Care Medicine of Australia and New Zealand Gastroenterological Society of Australia New Zealand Society for Gastroenterology Royal Australasian College

2014 Australian and New Zealand College of Anaesthetists

146. Guidelines on Sedation and/or Analgesia for Diagnostic and Interventional Medical, Dental or Surgical Procedures

should be discharged into the care of a responsible adult to whom written instructions should be given, including advice about eating and drinking, pain relief, and resumption of normal activities, as well as about making legally-binding decisions, driving, or operating machinery. 12.5 A system should be in place to enable safe transfer of the patient to appropriate medical care should the need arise. 13. TRAINING IN PROCEDURAL SEDATION AND/OR ANALGESIA FOR NON- ANAESTHETIST MEDICAL PRACTITIONERS (...) Guidelines on Sedation and/or Analgesia for Diagnostic and Interventional Medical, Dental or Surgical Procedures PS09 2014 Page 1 PS09 2014 Australian and New Zealand College of Anaesthetists (ANZCA) Faculty of Pain Medicine The following organisations have endorsed this document: Gastroenterological Society of Australia Royal Australasian College of Surgeons Australasian College for Emergency Medicine College of Intensive Care Medicine of Australia and New Zealand Royal Australian and New

2014 Australian and New Zealand College of Anaesthetists

147. Methodological Choices for the Clinical Development of Medical Devices

of comparing the efficacy of two treatments, a well-conducted double-blind randomised controlled trial is the type of study that offers the highest level of evidence, enabling medical decisions to be backed up (1) and the efficacy of these treatments to be evaluated (2). Randomisation, blinding and intention-to-treat analysis 1 are the main criteria with regard to methodological quality. In most cases, a randomised controlled trial can be performed. However, in some very specific situations that require (...) justification, conducting randomised controlled trials on medical devices (MDs) is known to be difficult for reasons relating to: o the inability to randomise o the choice of comparator o the difficulties of implementing a double-blind procedure o non-acceptance by the patient or clinician o subjective endpoints in certain situations . Other types of trials and observational studies should be reserved for situations where a conventional randomised controlled trial is not possible; the decision to use

2013 Haute Autorite de sante

148. Medical treatment of ectopic pregnancy: a committee opinion

, that the difference in failure rates between the two protocols may not be as dra- maticinwomenwithanoverallgoodprognosisforsuccessful medical treatment. Ahybridprotocol,involvingtwoequaldosesofMTX(50 mg/m 2 ) administered on days 1 and 4 without leucovorin rescue and follow-up as described previously for the single- dose protocol, may offer a more optimal balance between convenience and ef?cacy (37, 38). The protocol also allows TABLE 1 Contraindications to MTX therapy (25, 26, 29–31). Absolute contraindications (...) abortion Rhogam if Rh negative 1 hCG MTX 50 mg/m 2 IM 4 hCG 7 hCG MTX 50 mg/m 2 IM if b-hCG decreased 4 cm) High initial hCG concentration (>5,000 mIU/mL) Presence of free peritoneal blood Rapidly increasing hCG concentrations (>50%/48 h) before MTX Continued rapid rise in hCG concentrations during MTX Note: MTX¼ methotrexate. Practice Committee. Medical treatment of ectopic pregnancy. Fertil Steril 2013. VOL. 100 NO. 3 / SEPTEMBER 2013 641 Fertility and Sterility®ADJUNCTIVEUSEOFMTX A persistent

2013 Society for Assisted Reproductive Technology

149. Long-Term Medical Management of the Pediatric Patient After Liver Transplantation

Long-Term Medical Management of the Pediatric Patient After Liver Transplantation SPECIAL ARTICLE Long-Term Medical Management of the Pediatric Patient After Liver Transplantation: 2013 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation Deirdre A. Kelly, 1 John C. Bucuvalas, 2 Estella M. Alonso, 3 Saul J. Karpen, 4 Upton Allen, 5 Michael Green, 6 Douglas Farmer, 7 Eyal Shemesh, 8 and Ruth A. McDonald 9 1 Liver Unit (...) and the American Gastroenterological Association policy statement on the use of medical practice guidelines 2 ; and (4) the experience of the authors in managing children under- going liver transplantation (LT). Intended for use by pediatricians and physicians, these recommendations suggest preferred approaches to the diagnostic, thera- peutic, and preventive aspects of care. They are intended to be ?exible, in contrast to standards of care, which are in?exible policies to be followed in every case. Speci?c

2013 American Association for the Study of Liver Diseases

150. Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease

; and Departments of Neurology and Neurological Surgery (M.S.), Loyola Medicine, Maywood, IL. Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease Melissa J. Armstrong , Gary Gronseth , David C. Anderson , José Biller , Brett Cucchiara , Rima Dafer , Larry B. Goldstein , Michael Schneck , Steven R. Messé Neurology May 2013, 80 (22) 2065-2069; DOI: 10.1212/WNL.0b013e318294b32d Citation Manager Formats Make Comment See (...) clinical scenarios for guideline application are presented in . RECOMMENDATIONS It is axiomatic that clinicians managing antithrombotic medications periprocedurally weigh bleeding risks from drug continuation against TE risks from discontinuation at the individual patient level, although high-quality evidence on which to base this decision is often unavailable. In addition, even when evidence is insufficient to exclude a difference in bleeding or shows a small increase in clinically important bleeding

2013 American Academy of Neurology

151. Beyond Medications and Diet: Alternative Approaches to Lowering Blood Pressure

, and a substantial modification in medical education and training would be required to make acupuncture accessible and available for the management of hypertension in many regions of the world. In addition to logistical difficulties in the real-world setting, meta-analyses have reported a small risk of developing uncontrolled hypertension while deferring active medical treatment and the rare potential for minor adverse events, including pain and bleeding at needle sites. Given the paucity of data, no specific (...) Beyond Medications and Diet: Alternative Approaches to Lowering Blood Pressure Beyond Medications and Diet: Alternative Approaches to Lowering Blood Pressure | Hypertension Search Hello Guest! Login to your account Email Password Keep me logged in Search April 2019 March 2019 February 2019 January 2019 Free Access article Share on Jump to Free Access article Beyond Medications and Diet: Alternative Approaches to Lowering Blood Pressure A Scientific Statement From the American Heart Association

2013 American Heart Association

152. Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health

to determine the effectiveness of medications previously recommended for use in older children and adults ( ). We anticipate that, as more medications are studied in young children, evidence-based decision making for this vulnerable population will become easier. There has been a multiplication of delivery devices for inhaled medications designed to decrease administration time and improve efficacy. Inhaled therapeutics are often paired with a specific device optimized for delivery, creating the potential (...) . We have undertaken a new review of the literature to update the recommendations, including consideration of new medications and additional evidence on previously reviewed therapies. A multidisciplinary committee of experts in CF pulmonary care was established to review the evidence for use of chronic medications for CF lung disease and make treatment recommendations. Published evidence for chronic lung therapies was systematically reviewed and resulting treatment recommendations were graded based

2013 Cystic Fibrosis Foundation

153. Coping With the Stress of Medical Professional Liability Litigation

in decision making cannot be avoided throughout one’s career. One of the healthiest responses is recognition of the error and the development of a plan to decrease the likelihood of future similar occurrences. This activity often provides comfort and healing to the physician. Obstetrician–gynecologists should recognize that being a defendant in a medical professional liability lawsuit can be one of life’s most stressful experiences. Negative emotions in response to a lawsuit are normal and physicians may (...) Medical News. November 2, 2009. Available at: . Retrieved July 13, 2012. References Gold KJ, Kuznia AL, Hayward RA. How physicians cope with stillbirth or neonatal death: a national survey of obstetricians. Obstet Gynecol 2008;112:29–34. Waterman AD, Garbutt J, Hazel E, Dunagan WC, Levinson W, Fraser VJ, et al. The emotional impact of medical errors on practicing physicians in the United States and Canada. Jt Comm J Qual Patient Saf 2007;33:467–76. West CP, Huschka MM, Novotny PJ, Sloan JA, Kolars JC

2013 American College of Obstetricians and Gynecologists

154. Needs for medical devices for older people

for longer. With financial support from the Japanese Ministry of Health, Labour and Welfare, the WHO has begun research regarding this initiative in the Western Pacific Region. To prepare a foundation for future decisions, a detailed mapping of the need for medical devices for older people in the region is to be conducted. This will determine the technological needs for diagnosis and treatment of the diseases of this population. Further research and surveys will be conducted at a country-by-country level (...) Needs for medical devices for older people ROYAL AUSTRALASIAN COLLEGE OF SURGEONS SYSTEMATIC REVIEW ON NEEDS FOR MEDICAL DEVICES FOR OLDER PEOPLE ASERNIP-S REPORT NO. 81 Commissioned to the Australian Safety and Efficacy Register of New Interventional Procedures - Surgical (ASERNIP-S) by the World Health Organization (WHO) February 2013 Disclaimer WHO Systematic Review on Needed Devices for the Elderly | 2013 page 1 Contents WHO Systematic Review on Needed Devices for the Elderly | 2013 page 2

2013 ASERNIP-S

155. Electronic Medical Records (EMR) and Quality of Care

transitions to the new EMR. It’s a time of possibility and excitement as well as apprehension. However, we all have the opportunity to use this technology to improve our own practices and, ultimately influence more positive patient outcomes. Gill, J. M. (2009). EMRs for improving quality of care: promise and pitfalls. Family Medicine , 41 (7), 513–515. Hsiao, C. J., Marsteller, J. A., & Simon, A. E. (2014). Electronic Medical Record Features and Seven Quality of Care Measures in Physician Offices (...) . American Journal of Medical Quality , 29 (1), 44–52. doi:10.1177/1062860613483870 Lau, F., Lau, F., Price, M., Price, M., Boyd, J., Boyd, J., et al. (2012). Impact of electronic medical record on physician practice in office settings: a systematic review. Management Science , 36 (2), 123–139. doi:10.1186/1472-6947-12-10 Menachemi, N., & Collum. (2011). Benefits and drawbacks of electronic health record systems. Risk Management and Healthcare Policy , 47. doi:10.2147/RMHP.S12985 Menachemi, N., Ford, E

2018 Evidence-Based Nursing blog

156. Medical treatment of infantile spasms

. Trevathan E , Murphy CC , Yeargin-Allsopp M . The descriptive epidemiology of infantile spasms among Atlanta children . 4. Hattori H . Spontaneous remission of spasms in West syndrome: implications of viral infection . 5. Hrachovy RA , Glaze DG , Frost JD Jr . . A retrospective study of spontaneous remission and long-term outcome in patients with infantile spasms . 6. Mackay MT , Weiss SK , Adams-Webber T , et al . Practice parameter: medical treatment of infantile spasms: report of the American Academy (...) (dexamethasone palmitate) therapy for West syndrome: a comparative study with ACTH therapy . 20. Snead OC , Benton JW , Myers GJ . ACTH and prednisone in childhood seizure disorders . 21. Lux AL , Edwards SW , Hancock E , et al . The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial . 22. Mytinger JR , Quigg M , Taft WC , Buck ML , Rust RS . Outcomes in treatment of infantile spasms with pulse

2012 American Academy of Neurology

157. Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive Care Unit and the Emerging Need for New Medical Staffing and Training Models

decision making after rewarming. Multidisciplinary clinical collaboration and experienced clinical management are important to improve outcomes for such patients. As therapeutic hypothermia becomes applied more broadly, the evolution of the CICU must anticipate the growing needs of the heterogeneous group of patients with restoration of spontaneous circulation after cardiac arrest. End-of-Life Care in the CICU As a consequence of greater disease severity and expanded supportive technologies within (...) the CICU, end-stage disease states have become commonplace. Coordination of end-of-life care, including discussions with patients and families, decision making about deactivation of devices such as internal defibrillators, ethics consultation, pain management, and symptom relief, is now a central part of compassionate care in the CICU. Family members consistently emphasize the importance of effective communication in the intensive care environment and most often rank communication above clinical skills

2012 American Heart Association

158. First-trimester abortion in women with medical conditions

First-trimester abortion in women with medical conditions Clinical Guidelines First-trimester abortion in women with medical conditions Release date October 2012 SFP Guideline #20122 Abstract Most women undergoing first-trimester abortion are healthy. However, abortion providers also encounter women with a wide variety of medical conditions, some of which are serious and complex. When such a condition exists, consultation with the woman's physician or a specialist can facilitate decision making (...) . The decision to temporarily discontinue anticoagulation therapy will depend on the agent used and the underlying risk of thrombosis.AccordingtotheAmericanHeartAssociation,additionalantibioticsarenotrecommendedtopreventendocarditisinwomenwith cardiaclesionsduringsurgicalabortion.Wereviewspecificrecommendationsforwomenwithcommonmedicalconditions.Insomewomen, highly effective postabortion contraception is essential to prevent pregnancy-related morbidity. The U.S. Medical Eligibility Criteria for Contraceptive

2012 Society of Family Planning

159. Improving Medication Safety

workarounds that intentionally bypass safety features. Studies have shown that acceptance of a clinical decision support system is significantly improved if health care providers trust the system to help them take better care of their patients, the system reminds them of something they may have forgotten, or it provides them with information that was previously unavailable ( ). Patient Education and Shared Decision Making to Enhance Medication Safety Regardless of whether nonautomated or automated systems (...) . Washington, DC: National Academies Press; 2000. Kaushal R, Bates DW. Computerized physician order entry (CPOE) with clinical decision support systems (CDSSs). In: Agency for Healthcare Research and Quality. Making health care safer: a critical analysis of patient safety practices. Evidence Report/Technology Assessment No. 43. Rockville (MD): AHRQ; 2001. p. 59–69. Available at: . Retrieved April 2, 2012. Centers for Medicare and Medicaid Services. E-prescribing. Available at: . Retrieved April 2, 2012

2012 American College of Obstetricians and Gynecologists

160. An Interactive Patient-Centered Consent for Research Using Medical Records

to assess voluntary consent (Miller et. al.,2011); 9-items, 5-point Likert Scale (Strongly disagree-Strongly Agree) Change from Baseline Perceived Voluntariness [ Time Frame: 1-week follow-up from Baseline ] Decision Making Control instrument to assess voluntary consent (Miller et. al.,2011); 9-items, 5-point Likert Scale (Strongly disagree-Strongly Agree) Baseline Trust in medical researchers [ Time Frame: Prior to consent ] Trust In Medical Researchers Scale (Mainous et al. 2006); 12 items, 5-point (...) . An Interactive Patient-Centered Consent for Research Using Medical Records The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03063268 Recruitment Status : Active, not recruiting First Posted : February 24, 2017 Last Update Posted : February 18, 2019 Sponsor: University of Florida Collaborators: Richard M

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>